EUVIMEDEUVIMED entdecken
Open Access

miR-100-5p Enhances Cell Cycle-Mediated Chemoresistance by Modulating the CTDSPL/pRB/E2F1 Signaling Pathway in Oxaliplatin-Resistant Colorectal Cancer Cells

Yen-Pin Chen, Rathinasamy Baskaran, Hema Sri Devi, Chaouhan Hitesh Singh, Yu-Jung Lin, Marthandam Asokan Shibu, Wei-Wen Kuo, Shih-Chieh Liao, Ming-Cheng Chen, Tso-Fu Wang, Chi-Cheng Li, Tsung-Jung Ho und 3 weitere

Oncology Research · 2026

DOI: 10.32604/or.2026.073080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Yen-Pin Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, National Defense Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: MicroRNAs, Drug Resistance, Neoplasm, Colorectal Neoplasms, E2F1 Transcription Factor. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDrug Resistance, NeoplasmColorectal NeoplasmsE2F1 Transcription FactorPhosphoprotein PhosphatasesHumansOxaliplatinSignal TransductionGene Expression Regulation, NeoplasticCell Line, TumorCell CycleCell ProliferationApoptosisAntineoplastic Agents

Stichwörter der Autor:innen

C-terminal domain small phosphatase-like (CTDSPL)/retinoblastoma protein (pRB)/…cell cycle progressionchemoresistancecolorectal cancersmiR-100-5p

Substanzen

MicroRNAsOxaliplatinE2F1 Transcription FactorMIRN100 microRNA, humanE2F1 protein, humanAntineoplastic AgentsPhosphoprotein Phosphatases

Autor:innen und Institutionen

  • School of Medicine, National Defense Medical University, Taipei, Taiwan.
  • Department of Orthopedic Surgery, Tri-Service General Hospital, Taipei, Taiwan.
  • Department of Orthopedics, Taichung Armed Forces General Hospital, Taichung, Taiwan.
  • Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
  • Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan.
  • Department of Biotechnology, Bharathiar University, Coimbatore, India.

Zitieren

APA

Chen, Y. P., Baskaran, R., Devi, H. S., Singh, C. H., Lin, Y. J., Shibu, M. A., Kuo, W. W., Liao, S. C., Chen, M. C., Wang, T. F., Li, C. C., Ho, T. J., Shih, T. C., Lin, S. Z., & Huang, C. Y. (2026). miR-100-5p Enhances Cell Cycle-Mediated Chemoresistance by Modulating the CTDSPL/pRB/E2F1 Signaling Pathway in Oxaliplatin-Resistant Colorectal Cancer Cells. Oncology Research. https://doi.org/10.32604/or.2026.073080

Vancouver

Chen YP, Baskaran R, Devi HS, Singh CH, Lin YJ, Shibu MA, et al. miR-100-5p Enhances Cell Cycle-Mediated Chemoresistance by Modulating the CTDSPL/pRB/E2F1 Signaling Pathway in Oxaliplatin-Resistant Colorectal Cancer Cells. Oncology Research. 2026. doi:10.32604/or.2026.073080

BibTeX
@article{Chen2026,
  author = {Chen, Yen-Pin and Baskaran, Rathinasamy and Devi, Hema Sri and Singh, Chaouhan Hitesh and Lin, Yu-Jung and Shibu, Marthandam Asokan and Kuo, Wei-Wen and Liao, Shih-Chieh and Chen, Ming-Cheng and Wang, Tso-Fu and Li, Chi-Cheng and Ho, Tsung-Jung and Shih, Tzu-Ching and Lin, Shinn-Zong and Huang, Chih-Yang},
  title = {miR-100-5p Enhances Cell Cycle-Mediated Chemoresistance by Modulating the CTDSPL/pRB/E2F1 Signaling Pathway in Oxaliplatin-Resistant Colorectal Cancer Cells},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2026.073080}
}
Kostenlos starten →